Effect of  - and  -adrenergic stimulation on the uterine motility and adenosine 3'5'-monophosphate level.
D000818:Animals; D001464:Barium / Q000494:pharmacology; D002082:Butylamines / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D002855:Chromatography, Thin Layer; D000242:Cyclic AMP / Q000032:analysis*; D004347:Drug Interactions; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011941:Receptors, Adrenergic / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D014599:Uterus / Q000032:analysis / Q000187:drug effects*
D002082:Butylamines; D002395:Catecholamines; D011941:Receptors, Adrenergic; D013565:Sympatholytics; D010643:Phenoxybenzamine; D001464:Barium; D010121:Oxytocin; D011433:Propranolol; D000242:Cyclic AMP; D008729:Methoxamine; D007545:Isoproterenol; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine